 |
| August
28, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Jason Cole, CEO and Board Member, Zag Bio,
Inc. |
| In
this week’s CEO Q&A, Cole, who lives
with type 1 diabetes himself, discusses
the science behind Zag’s thymus-targeted
platform, what differentiates its approach
from other immune-tolerance strategies in
development, and his outlook for turning
immune tolerance from long-standing
scientific aspiration into real therapies
for patients. More |
|
|
- CREATE Medicines: Expands Clinical In Vivo
CAR Pipeline and LNP Technology Suite by
Forming Strategic Collaboration With WestGene
More
- Harbour BioMed: 2026 Interim Results - Three
Integrated Growth Engines Accelerate Execution
of Its Platform-Based Strategy More
- MBX Biosciences: First Patient Dosed in
Pivotal Phase 3 oPTimize Trial of Once-Weekly
Canvuparatide in Adults With
Hypoparathyroidism More
- Moderna: Receives U.S. FDA Approval for
Updated 2026-2027 COVID-19 Vaccines More
- Thermo Fisher Scientific: Introduces the
Thermo Scientific EMPAD G2 Electron Detector
to Advance Materials Research More
|
|
 |
CRCFO
Advisory
Reassessing your business plan?
We provide financial leadership.
Smart. Nimble. Flexible. |
|
Learn More
→ |
|
|
- Boston Biotech Bicara Signs Sublease for
Wayfair Space More*
- LSN: Hot Investor Mandates (Updated 8/25) More
- Moderna: Pricing of Upsized $2.6 Billion
Offering of Convertible Senior Notes More
More*
More*
More*
- ProFound Therapeutics Receives Investment
to Tackle Preeclampsia and Eclampsia More
More
More
More
|
|
|
 |
Pace®
Life Sciences
The CDMO That Takes You Further.
Your partner for Product
Development, Manufacturing,
Analytical Testing, Regulatory
Consulting & Operational
Support. |
|
Learn More
→ |
|
|
- After Some 'Tough Years,' Frontier’s CEO Is
Ramping Up Ambitions for Precision Med
Platform More
- Alnylam’s Heart Drug Troubles Take Center
Stage at a Cardiology Conference More*
- Big4Bio CEO Weekly Q&A: Jason
Cole, CEO and Board Member, Zag Bio, Inc. More
- BioPharmGuy News: 2nd Place Finish, Sugar
Problems, Ghost Roast, Mummy Issues, Fruit
Buds More
- Biotech & Pharma Updates | August 27,
2026 More
- Michael Polansky Has a New, Skin-Focused
Biotech. Don’t Call It a Drug Company. More
- More on Generate Bio Lifting Lid on
Anti-TSLP mAb Findings in COPD After Leak More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Mystery of Moderna’s Magic Algorithm More*
|
|
- Harbour BioMed: Appoints Mr. Youchen Chen
and Dr. Ian Y. Liu as Executive Directors More
- OPPORTUNITY: Chief Operating Officer, Remote
More
- OPPORTUNITY: Computational Scientist, New
York More
- OPPORTUNITY: Head of
Computational Method Development, Boston
More
- Oryon Cell Therapies: Appoints Kenny
Choi, Ph.D. as Chief Technical Officer More
- Slone Partners: Fractional
Leadership in Biotech and Life Sciences -
When it Works and Why More
- Slone Partners: Places Farhad Ghavami as
Chief Executive Officer at SeqCenter More
- Vascular
Technology: Appoints David Pierce to Board of
Directors More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
